share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

SEC announcement ·  Jun 6 06:17
Summary by Futu AI
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on June 3, 2024. A total of 13,097 shares of Class A Common Stock were acquired at no cost, as part of the grant. Following this transaction, Li directly holds 72,186 shares of the company's stock. Additionally, Li has indirect beneficial ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on June 3, 2024. A total of 13,097 shares of Class A Common Stock were acquired at no cost, as part of the grant. Following this transaction, Li directly holds 72,186 shares of the company's stock. Additionally, Li has indirect beneficial ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.